USANA Health Sciences, Inc. (NYSE: USNA) reported Q1 EPS of $1.15, $0.15 worse than the analyst estimate of $1.30. Revenue for the quarter came in at $118.6 million versus the consensus estimate of $185.85 million.

For earnings history and earnings-related data on USANA Health Sciences, Inc. (USNA) click here.